386924004: Brimonidine tartrate (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Adrenergic receptor agonist\Alpha adrenergic receptor agonist\Alpha-2 adrenergic receptor agonist\Brimonidine tartrate (substance)

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Autonomic agent (substance)\Sympathomimetic agent (substance)\Adrenergic receptor agonist\Alpha adrenergic receptor agonist\Alpha-2 adrenergic receptor agonist\Brimonidine tartrate (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole\Imidazole\Brimonidine tartrate (substance)

\Organic compound\Organic cyclic compound\Heterocyclic compound\Quinoxaline (substance)\Brimonidine tartrate (substance)
\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Imidazole\Brimonidine tartrate (substance)
\Organic compound\Organic nitrogen compound\Azole\Imidazole\Brimonidine tartrate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1461102018 Brimonidine tartrate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1481038015 Brimonidine tartrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

6381000188116 brimonidine tartrate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

795631000172117 tartrate de brimonidine fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Brimonidine tartrate (substance)	Is a	Brimonidine (substance)	false	Inferred relationship	Some
Brimonidine tartrate (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Alpha-2 adrenergic receptor agonist (disposition)	true	Inferred relationship	Some
Brimonidine tartrate (substance)	Is a	Quinoxaline (substance)	true	Inferred relationship	Some
Brimonidine tartrate (substance)	Is a	Imidazole	true	Inferred relationship	Some
Brimonidine tartrate (substance)	This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged.	Brimonidine (substance)	true	Inferred relationship	Some
Brimonidine tartrate (substance)	Is a	Adrenergic receptor agonist	false	Inferred relationship	Some
Brimonidine tartrate (substance)	Is a	Alpha-2 adrenergic receptor agonist	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Brimonidine tartrate	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brimonidine tartrate (substance)	Inferred relationship	Some
Product containing precisely brimonidine tartrate 2 milligram/1 milliliter conventional release eye drops (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brimonidine tartrate (substance)	Inferred relationship	Some
Brimonidine tartrate 0.2% solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brimonidine tartrate (substance)	Inferred relationship	Some
Brimonidine tartrate 1.5 mg/mL eye solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brimonidine tartrate (substance)	Inferred relationship	Some
Product containing precisely brimonidine tartrate 1 milligram/1 milliliter conventional release eye solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brimonidine tartrate (substance)	Inferred relationship	Some
Brimonidine 0.2%/timolol 0.5% eye drops	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Brimonidine tartrate (substance)	Inferred relationship	Some
Product containing precisely brimonidine tartrate 2 milligram/1 milliliter conventional release eye drops (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brimonidine tartrate (substance)	Inferred relationship	Some	1
Product containing precisely brimonidine tartrate 2 milligram/1 milliliter conventional release eye drops (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brimonidine tartrate (substance)	Inferred relationship	Some	1
Brimonidine tartrate 1.5 mg/mL eye solution	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brimonidine tartrate (substance)	Inferred relationship	Some	1
Brimonidine tartrate 1.5 mg/mL eye solution	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brimonidine tartrate (substance)	Inferred relationship	Some	1
Product containing precisely brimonidine tartrate 1 milligram/1 milliliter conventional release eye solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brimonidine tartrate (substance)	Inferred relationship	Some	1
Product containing precisely brimonidine tartrate 1 milligram/1 milliliter conventional release eye solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brimonidine tartrate (substance)	Inferred relationship	Some	1
Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brimonidine tartrate (substance)	Inferred relationship	Some	2
Product containing precisely brimonidine tartrate 2 milligram/1 milliliter and timolol 5 milligram/1 milliliter conventional release eye solution (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brimonidine tartrate (substance)	Inferred relationship	Some	2
Brimonidine (as brimonidine tartrate) 3.3 mg/g cutaneous gel	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brimonidine tartrate (substance)	Inferred relationship	Some	1
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Brimonidine tartrate (substance)	Inferred relationship	Some	1
Brimonidine tartrate 2 mg/mL and brinzolamide 10 mg/mL eye drops suspension	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Brimonidine tartrate (substance)	Inferred relationship	Some	1

This concept is not in any reference sets